Virtual meeting
Via Zoom
Description
As part of the twice-monthly SUD Care Continuum ECHO® series, Robert Lowe, MD, will improve interdisciplinary coordination in the identification and management of alcohol-related liver disease among patients with alcohol use disorder and recognize key risk factors, clinical features, and stages of alcohol-related liver disease relevant to addiction treatment settings. He will also apply evidence-informed strategies for screening, assessment, treatment, and referral for patients with alcohol-related liver disease. The didactic will be followed by a de-identified patient case presentation from an ECHO® participant and recommendations from the panel of experts and attendees.
The Substance Use Disorder Care Continuum ECHO® (SUD Care Continuum ECHO®) series offers training and support in addiction treatment, with a focus on supporting front line addiction treatment workforce. This includes health providers in Acute Treatment Services (ATS), Crisis Stabilization Services (CSS), Transitional Support Services (TSS), Opioid Treatment Programs (OTP), long-term residential program, sober and recovery homes, primary care, and psychiatry. This free, case-based tele-mentoring program is designed to increase the capacity of health care providers to implement high-quality and evidence-based addiction treatment.
Intended audience
Providers, nurses, social workers, psychologists, peer supports, other clinical staff, and non-clinicians.
Speakers
Robert Lowe, MD
Robert C Lowe, MD, is a gastroenterologist at Boston Medical Center (BMC). Dr. Lowe is also an associate professor of Gastroenterology and Assistant Dean for Medical Education at Boston University Chobanian & Avedisian School of Medicine. He received his medical degree from Harvard Medical School, completed his residency and chief residency at Brigham and Women’s Hospital, and has been in practice for more than 25 years. Dr. Lowe has expertise in gastroenterology and hepatology, and is the recipient of numerous teaching awards, including the Stanley Robbins Award, the Metcalf Award and the Grant V. Rodkey Award for Outstanding Contributions to Medical Education from the Massachusetts Medical Society.
Objectives
Following this training, participants will have the knowledge to:
1. Improve interdisciplinary coordination in the identification and management of alcohol-related liver disease among patients with alcohol use disorder.
2. Recognize key risk factors, clinical features, and stages of alcohol-related liver disease relevant to addiction treatment settings.
3. Apply evidence-informed strategies for screening, assessment, treatment, and referral for patients with alcohol-related liver disease.
Sponsored by
Massachusetts Department of Public Health, Bureau of Substance Addiction Services (DPH/BSAS)
Accreditation information
Please read the Accreditation Information section of the training registration page for accreditation details and to learn about the requirements for receiving credit or a certificate of completion.
